期刊文献+

减重手术对肠道菌群及代谢性炎症综合征影响的研究进展

Research progress on the effect of bariatric surgery on intestinal flora and metabolic inflammatory syndrome
原文传递
导出
摘要 减重手术目前是治疗肥胖及其相关代谢疾病最有效的方式,近年来受到越来越多的关注。肠道菌群失调是代谢性炎症过程的重要激发因素,减重手术在减轻体重的同时也改变了肠道菌群,肠道菌群的变化在一定程度上改善患者的血糖、血压、血脂和胰岛素抵抗水平,有助于减轻机体炎症状态和维持减重效果。本文就减重手术对肠道菌群、肥胖、动脉粥样硬化(AS)、2型糖尿病(T2DM)和非酒精性脂肪肝(NAFLD)的影响及相关机制的研究进展作一综述。 Bariatric surgery is currently the most effective way to treat obesity and its related metabolic diseases,and has attracted more and more attention in recent years.Dysbiosis of intestinal flora is an important trigger for metabolic inflammatory process.Bariatric surgery changes the gut microbiota as well as the weight loss,the changes of gut microbiota can improve the blood glucose,blood pressure,blood lipids and insulin resistance of patients to some extent,and help to reduce the inflammatory state and maintain the weight loss of the body.In this review,the effects of bariatric surgery on the intestinal flora,obesity,atherosclerosis(AS),T2DM and NAFLD and the related mechanisms were reviewed.
作者 邓垚 谢壁成 吴边 兰丹凤 Deng Yao;Xie Bicheng;Wu Bian;Lan Danfeng(Department of Gastroenterology,The First People's Hospital of Yunnan Province,650032 Kunming,China;Yunnan Digestive Disease Clinical Medical Center,650032 Kunming,China;Department of Gastrointestinal and Bariatric Metabolic Surgery,The First People's Hospital of Yunnan Province,650032 Kunming,China;Yunnan Key Laboratory of Innovative Application of Traditional Chinese Medicine,650032 Kunming,China)
出处 《中华肥胖与代谢病电子杂志》 2025年第1期70-75,共6页 Chinese Journal Of Obesity and Metabolic Diseases:Electronic Edition
基金 云南省“兴滇英才计划”青年拔尖人才专项(YNWRQNBJ-2020-236) 昆明理工大学-云南省第一人民医院医学联合专项基金(KUST-KH2022013Y) 云南省科技厅-昆明医科大学应用基础研究联合专项(202301AY070001-058、202401AY070001-040)
关键词 减重手术 肠道菌群 动脉粥样硬化 2型糖尿病 非酒精性脂肪肝 Bariatric surgery Intestinal flora Atherosclerosis Type 2 diabetes mellitus Nonalcoholic fatty liver disease
  • 相关文献

参考文献2

二级参考文献35

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3093
  • 2RAMACHANDRAN A,MA R C, SNEHALATHA C.Diabetes in Asia[J]. Lancet, 2010, 375(9712). : 408-418.
  • 3YANG S H,DOU K F, SONG W J. Prevalence of diabetesamong men and women in China[J]. N Engl J Med, 2010,362(25). : 2425-2426.
  • 4MINGRONE G, PANUNZI S,DE GAETANO A, et al.Bariatric surgery versus conventional medical therapy fortype 2 diabetes[J]. N Engl J Med, 2012,366(17).: 1577-1585.
  • 5SCHAUER P R,KASHYAP S R, WOLSKI K, et al.Bariatric surgery versus intensive medical therapy in obesepatients with diabetes[J]. N Engl J Med, 2012 , 366(17).:1567-1576.
  • 6LAKDAWALA M,BHASKER A, Asian ConsensusMeeting on Metabolic Surgery (ACMOMS).. Report : AsianConsensus Meeting on Metabolic Surgery. Recommendationsfor the use of Bariatric and Gastrointestinal MetabolicSurgery for Treatment of Obesity and Type H DiabetesMellitus in the Asian Population: August 9th and 10th,2008, Trivandrum, India [J]. Obes Surg, 2010, 20 ( 7).:929-936.
  • 7KAO Y H, LO C H,HUANG C K. Relationship ofbypassed limb length and remission of type 2 diabetesmellitus after Roux-en-Y gastric bypass[J]. Surg Obes RelatDis, 2012,8(6). : e82-e84.
  • 8HUANG C K, LEE Y C, HUNG C M,et al. LaparoscopicRoux-en-Y gastric bypass for morbidly obese Chinesepatients: learning curve, advocacy and complications [J].Obes Surg, 2008, 18(7).: 776-781.
  • 9GOLDNER W S, STONER J A, LYDEN E, et al. Findingthe optimal dose of vitamin D following Roux-en-Y gastricbypass: a prospective, randomized pilot clinical trial [J].Obes Surg, 2009,19(2).: 173-179.
  • 10UN E,ARMSTRONG-MOORE D,LIANG Z, et al.Contribution of adipose tissue to plasma 2 5-hydroxy vitaminD concentrations during weight loss following gastric bypasssurgery [J]. Obesity (Silver Spring). , 2011,19 (3).:588-594.

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部